I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Interleukin (IL)-19 and IL-20 are important members of the IL-10 cytokine family, which are known to play a role in inflammatory processes. Both anti-IL-19 and -IL-20 targeting drugs have been suggested in the treatment of inflammatory diseases such as psoriasis and rheumatoid arthritis. Recently, we presented I-kappa-B-zeta (IκBζ) as a key player in psoriasis by identifying IκBζ as a regulator of IL-17/tumor necrosis factor (TNF)α-inducible psoriasisassociated genes and proteins. Some of these genes were synergistically regulated by IL-17/TNFα. Objective: The purpose of this study was to explore the role of IκBζ in the regulation of IL-17A/TNFα-mediated induction of IL-19 and IL-20 expression in human keratinocytes. Methods: In vitro experiments with cultured primary humane keratinocytes were conducted and investigated by quantitative polymerase chain reaction (qPCR), Western blotting, ELISA and EMSA. For statistics, a one- or two- way repeated-measures analysis of variance (RM ANOVA) or the Friedman test (a nonparametric equivalent to the RM ANOVA) were conducted. Results: We demonstrated that IL-19 and IL-20 mRNA and protein expressions were synergistically induced by IL-17A and TNFα, whereas IL-17A and TNFα alone had only a minor effect on the IL-19 and IL-20 expression. Moreover, we demonstrated IκBζ to be a regulator of this synergistic induction of IL-19 and IL-20. Finally, the IL-17A/TNFα-induced synergistic induction of IL-19 and IL-20 expression was found to be mediated by a p38 MAPK-, NF-κB- and JNK1/2-dependent mechanism. Conclusion: This study demonstrates that IκBζ plays a role in the IL-17A/TNFα-mediated synergistic induction of IL-19 and IL-20 in humane keratinocytes.
Abstract
Background: Interleukin (IL)-19 and IL-20 are important members of the IL-10 cytokine family, which are known to play a role in inflammatory processes. Both anti-IL-19 and -IL-20 targeting drugs have been suggested in the treatment of inflammatory diseases such as psoriasis and rheumatoid arthritis. Recently, we presented I-kappa-B-zeta (IκBζ) as a key player in psoriasis by identifying IκBζ as a regulator of IL-17/tumor necrosis factor (TNF)α-inducible psoriasisassociated genes and proteins. Some of these genes were synergistically regulated by IL-17/TNFα. Objective: The purpose of this study was to explore the role of IκBζ in the regulation of IL-17A/TNFα-mediated induction of IL-19 and IL-20 expression in human keratinocytes. Methods: In vitro experiments with cultured primary humane keratinocytes were conducted and investigated by quantitative polymerase chain reaction (qPCR), Western blotting, ELISA and EMSA. For statistics, a one- or two- way repeated-measures analysis of variance (RM ANOVA) or the Friedman test (a nonparametric equivalent to the RM ANOVA) were conducted. Results: We demonstrated that IL-19 and IL-20 mRNA and protein expressions were synergistically induced by IL-17A and TNFα, whereas IL-17A and TNFα alone had only a minor effect on the IL-19 and IL-20 expression. Moreover, we demonstrated IκBζ to be a regulator of this synergistic induction of IL-19 and IL-20. Finally, the IL-17A/TNFα-induced synergistic induction of IL-19 and IL-20 expression was found to be mediated by a p38 MAPK-, NF-κB- and JNK1/2-dependent mechanism. Conclusion: This study demonstrates that IκBζ plays a role in the IL-17A/TNFα-mediated synergistic induction of IL-19 and IL-20 in humane keratinocytes.
참고문헌 (27)
- Sabat R, "IL-10 family of cytokines", Cytokine Growth Factor Rev, 21, pp.315~324 (2010)
- Blumberg H, "Interleukin 20: discovery, receptor identification, and role in epidermal function", Cell, 104, pp.9~19 (2001)
- Stenderup K, "Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model", Br J Dermatol, 160, pp.284~296 (2009)
- Parrish-Novak J, "Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions", J Biol Chem, 277, pp.47517~47523 (2002)
- Rømer J, "Epidermal overexpression of interleukin-19and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol", J Invest Dermatol, 121, pp.1306~1311 (2003)
- Gallagher G, "Interleukin-19 : multiple roles in immune regulation and disease", Cytokine Growth Factor Rev, 21, pp.345~352 (2010)
- Otkjaer K, "The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis", Br J Dermatol, 153, pp.911~918 (2005)
- Galimova E, "Interleukin-10 family cytokines pathway : genetic variants and psoriasis", Br J Dermatol, 176, pp.1577~1587 (2017)
- Wegenka UM, "IL-20 : biological functions mediated through two types of receptor complexes", Cytokine Growth Factor Rev, 21, pp.353~363 (2010)
- Hsu YH, "IL-20 in rheumatoid arthritis", Drug Discov Today, 22, pp.960~964 (2017)
- Nestle FO, "Mechanisms of disease : psoriasis", N Engl J Med, 361, pp.496~509 (2009)
- Chapman A, "Comorbidity in rheumatic diseases", pp.81~124 (2017), Springer
- Wei CC, "Detection of IL-20 and its receptors on psoriatic skin", Clin Immunol, 117, pp.65~72 (2005)
- Kunz S, "Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs", Exp Dermatol, 15, pp.991~1004 (2006)
- Li HH, "Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis", Br J Dermatol, 153, pp.591~595 (2005)
- Sa SM, "The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis", J Immunol, 178, pp.2229~2240 (2007)
- Liao YC, "IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha", J Immunol, 169, pp.4288~4297 (2002)
- Autieri MV, "IL-19 and other IL-20 family member cytokines in vascular inflammatory diseases", Front Immunol, 9, pp.700~ (2018)
- Johansen C, "IκBζ is a key driver in the development of psoriasis", Proc Natl Acad Sci U S A, 112, pp.E5825~E5833 (2015)
- Bertelsen T, "The human IL-17A", F heterodimer regulates psoriasis-associated genes through I κBζ, 2018, pp.27, 1048~1052
- Bertelsen T, "IL-17F regulates psoriasis-associated genes through IκBζ", Exp Dermatol, 26, pp.234~241 (2017)
- Muta T, "IkappaB-zeta : an inducible regulator of nuclear factor-kappaB", Vitam Horm, 74, pp.301~316 (2006)
- Okamoto K, "IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors", Nature, 464, pp.1381~1385 (2010)
- Johansen C, "Generation and culturing of primary human keratinocytes from adult skin", J Vis Exp, (130), pp.56863~ (2017)
- Chiricozzi A, "Integrative responses to IL-17and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis", J Invest Dermatol, 131, pp.677~687 (2011)
- Johansen C, "Characterization of TNF-α- and IL-17A-mediated synergistic induction of DEFB4 gene expression in human keratinocytes through IκBζ", J Invest Dermatol, 136, pp.1608~1616 (2016)
- Russell CB, "Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17receptor monoclonal antibody", J Immunol, 192, pp.3828~3836 (2014)